This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Agri Ibrahim Cecen Universitesi Strateji Daire Bask., Bahçesehir Üniversitesi, Istanbul Gedik Universitesi. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 18 
1 out of 2 Years Active: 2021-2026
Title: The Innovative Contributions of Serdar Durdagi
Introduction
Serdar Durdagi is a prominent inventor based in Istanbul, Turkey. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative inventions. With a total of 2 patents, Durdagi's work focuses on developing novel therapeutic compounds.
Latest Patents
One of his latest patents is the MAO-B inhibitor DRG-MAOB-1, which is designed for use in the treatment of neurodegenerative diseases. This invention relates to a compound represented by a specific formula or a pharmaceutically acceptable derivative that acts as a novel inhibitor of MAO-B. Another significant patent involves heterobivalent ligands suitable for treating Parkinson's disease. This patent discloses novel drug molecules and their application in addressing neurodegenerative diseases, particularly Parkinson's disease.
Career Highlights
Throughout his career, Serdar Durdagi has worked with esteemed institutions such as Bahçesehir University and Istanbul Gedik University. His academic and research endeavors have contributed to advancements in medical science and therapeutic development.
Collaborations
Durdagi has collaborated with notable colleagues, including Mine Yurtsever and Gülru Kayik. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Serdar Durdagi's contributions to the field of neurodegenerative disease treatment through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile